Your browser doesn't support javascript.
loading
Modulation of Morphine Analgesia, Antinociceptive Tolerance, and Mu-Opioid Receptor Binding by the Cannabinoid CB2 Receptor Agonist O-1966.
Reichenbach, Zachary W; DiMattio, Kelly; Rajakaruna, Suren; Ambrose, David; Cornwell, William D; Tallarida, Ronald J; Rogers, Thomas; Liu-Chen, Lee-Yuan; Tuma, Ronald F; Ward, Sara Jane.
Afiliação
  • Reichenbach ZW; Center for Substance Abuse Research (CSAR), Department of Neural Sciences, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, United States.
  • DiMattio K; Department of Gastroenterology and Hepatology, Temple University Hospital, Philadelphia, PA, United States.
  • Rajakaruna S; Center for Substance Abuse Research (CSAR), Department of Neural Sciences, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, United States.
  • Ambrose D; Center for Inflammation, Translational, and Clinical Lung Research, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, United States.
  • Cornwell WD; Center for Inflammation, Translational, and Clinical Lung Research, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, United States.
  • Tallarida RJ; Center for Inflammation, Translational, and Clinical Lung Research, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, United States.
  • Rogers T; Center for Substance Abuse Research (CSAR), Department of Neural Sciences, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, United States.
  • Liu-Chen LY; Center for Inflammation, Translational, and Clinical Lung Research, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, United States.
  • Tuma RF; Center for Substance Abuse Research (CSAR), Department of Neural Sciences, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, United States.
  • Ward SJ; Center for Substance Abuse Research (CSAR), Department of Neural Sciences, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, United States.
Front Pharmacol ; 13: 803331, 2022.
Article em En | MEDLINE | ID: mdl-35529434

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article